Predictive Risk Factors for Restenosis after Remote Superficial Femoral Artery Endarterectomy

European Journal of Vascular and Endovascular Surgery

Volumn 39, Issue 5, 2010, Pages 597-603

  Derksen, W J M ^a   Gisbertz, S S ^b   Hellings, W E ^a   Vink, A ^a   de Kleijn, D P V ^c   de Vries, J P P M ^b   Moll, F L ^a   Pasterkamp, G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

Arterial occlusive disease; Atherosclerosis; Predictive value; Remote endarterectomy; Restenosis; Superficial femoral artery

Indexed keywords

ADULT; AGE; AGED; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROTIC PLAQUE; COHORT ANALYSIS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE DURATION; ENDARTERECTOMY; FEMALE; HAZARD RATIO; HUMAN; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTENOSIS; RISK ASSESSMENT; RISK FACTOR; SUPERFICIAL FEMORAL ARTERY; WALKING DIFFICULTY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOGRAPHY, DIGITAL SUBTRACTION; ARTERIAL OCCLUSIVE DISEASES; CONSTRICTION, PATHOLOGIC; ENDARTERECTOMY; FEMALE; FEMORAL ARTERY; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY; WALKING;

EID: 77951621576     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2010.01.015     Document Type: Article

References (25)

1. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., and Fowkes F.G. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45 Suppl. S (2007) S5-S67
2. Gisbertz S.S., Ramzan M., Tutein Nolthenius R.P., van der Laan L., Overtoom T.T., Moll F.L., et al. Short-term results of a randomized trial comparing remote endarterectomy and supragenicular bypass surgery for long occlusions of the superficial femoral artery [the REVAS trial]. Eur J Vasc Endovasc Surg 37 (2009) 68-76
3. Smeets L., Huijbregts H.J., Ho G.H., De Vries J.P., and Moll F.L. Clinical outcome after re-occlusion of initially successful remote endarterectomy of the superficial femoral artery. J Cardiovasc Surg (Torino) 48 (2007) 309-314
4. Ho G.H., van Buren P.A., Moll F.L., van der Bom J.G., and Eikelboom B.C. Incidence, time-of-onset, and anatomical distribution of recurrent stenoses after remote endarterectomy in superficial femoral artery occlusive disease. J Vasc Surg 30 (1999) 106-113
5. Owens C.D., Ho K.J., and Conte M.S. Risk factors for failure of lower-extremity revascularization procedures: are they different for bypass and percutaneous procedures?. Semin Vasc Surg 21 (2008) 143-153
6. Verhoeven B.A., Velema E., Schoneveld A.H., de Vries J.P., de Bruin P., Seldenrijk C.A., et al. Athero-express: differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design. Eur J Epidemiol 19 (2004) 1127-1133
7. Rutherford R.B., Baker J.D., Ernst C., Johnston K.W., Porter J.M., Ahn S., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997) 517-538
8. Ho G.H., Moll F.L., Joosten P.P., van de Pavoordt E.D., and Overtoom T.T. The Mollring Cutter remote endarterectomy: preliminary experience with a new endovascular technique for treatment of occlusive superficial femoral artery disease. J Endovasc Surg 2 (1995) 278-287
9. Ho G.H., van Buren P.A., Moll F.L., van der Bom J.G., and Eikelboom B.C. The importance of revision of early restenosis after endovascular remote endarterectomy in SFA occlusive disease. Eur J Vasc Endovasc Surg 19 (2000) 35-42
10. Schanzer A., Hevelone N., Owens C.D., Belkin M., Bandyk D.F., Clowes A.W., et al. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg 46 (2007) 1180-1190
11. O'Connor N.J., Morton J.R., Birkmeyer J.D., Olmstead E.M., and O'Connor G.T. Effect of coronary artery diameter in patients undergoing coronary bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation 93 (1996) 652-655
12. Ozdemir M., Timurkaynak T., Tulmac M., Cemri M., Boyaci B., Yalcin R., et al. Early and late outcome of stenting in a consecutive series of patients with coronary lesions in vessels less than 2.8 mm in diameter. Jpn Heart J 44 (2003) 163-177
13. Togni M., Eber S., Widmer J., Billinger M., Wenaweser P., Cook S., et al. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial. J Am Coll Cardiol 50 (2007) 1123-1131
14. Meier B., Sousa E., Guagliumi G., Van den Branden F., Grenadier E., Windecker S., et al. Sirolimus-eluting coronary stents in small vessels. Am Heart J 151 (2006) 1019
15. Fisher L.D., Kennedy J.W., Davis K.B., Maynard C., Fritz J.K., Kaiser G., et al. Association of sex, physical size, and operative mortality after coronary artery bypass in the Coronary Artery Surgery Study (CASS). J Thorac Cardiovasc Surg 84 (1982) 334-341
16. Goldman S., Copeland J., Moritz T., Henderson W., Zadina K., Ovitt T., et al. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. Circulation 77 (1988) 1324-1332
17. Pasterkamp G., Wensing P.J., Post M.J., Hillen B., Mali W.P., and Borst C. Paradoxical arterial wall shrinkage may contribute to luminal narrowing of human atherosclerotic femoral arteries. Circulation 91 (1995) 1444-1449
18. Vink A., Schoneveld A.H., Borst C., and Pasterkamp G. The contribution of plaque and arterial remodeling to de novo atherosclerotic luminal narrowing in the femoral artery. J Vasc Surg 36 (2002) 1194-1198
19. Clark T.W., Groffsky J.L., and Soulen M.C. Predictors of long-term patency after femoropopliteal angioplasty: results from the STAR registry. J Vasc Interv Radiol 12 (2001) 923-933
20. DeRubertis B.G., Pierce M., Chaer R.A., Rhee S.J., Benjeloun R., Ryer E.J., et al. Lesion severity and treatment complexity are associated with outcome after percutaneous infra-inguinal intervention. J Vasc Surg 46 (2007) 709-716
21. Surowiec S.M., Davies M.G., Eberly S.W., Rhodes J.M., Illig K.A., Shortell C.K., et al. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg 41 (2005) 269-278
22. Nguyen L.L., Lipsitz S.R., Bandyk D.F., Clowes A.W., Moneta G.L., Belkin M., et al. Resource utilization in the treatment of critical limb ischemia: the effect of tissue loss, comorbidities, and graft-related events. J Vasc Surg 44 (2006) 971-975
23. Tangelder M.J., Algra A., Lawson J.A., and Eikelboom B.C. Risk factors for occlusion of infrainguinal bypass grafts. Eur J Vasc Endovasc Surg 20 (2000) 118-124
24. Pomposelli F.B., Kansal N., Hamdan A.D., Belfield A., Sheahan M., Campbell D.R., et al. A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg 37 (2003) 307-315
25. Lenti M., Cieri E., De Rango P., Pozzilli P., Coscarella C., Bertoglio C., et al. Endovascular treatment of long lesions of the superficial femoral artery: results from a multicenter registry of a spiral, covered polytetrafluoroethylene stent. J Vasc Surg 45 (2007) 32-39